Michael J. Keating
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Pfizer (United States)(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia(2002)5,000 cited
- → Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines(2008)3,177 cited
- → Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors(2020)2,047 cited
- → iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL(2018)1,646 cited
- → Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy(1997)1,153 cited
- → CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients